Company

About Us

Global Instrumentation was founded in 2002 with the goal of providing cost-effective and high-quality ECG monitoring solutions to the clinical research and healthcare sectors. We pioneered many of the first advancements in the field of digital Holter monitoring including internet connectivity. Based in Manlius, NY, Global Instrumentation has in-house expertise in the areas of medical device design, algorithm development, cloud-based remote monitoring systems, manufacturing, and regulatory compliance. We offer unique and complete ECG diagnostic solutions from development to approval and production to life cycle management.

We design, build, and sell ECG-based monitoring systems under our own name, and also license our technology to partner clients for private label branding. Our B2B business model allows our clients in clinical research, remote patient monitoring, and medical technology healthcare solutions to rapidly integrate our existing technology or develop new custom products without the need to expand their internal engineering and product support staff.

Our Commitment to Quality

Global Instrumentation, along with the management team and all of its employees is committed to:

  • Providing software, devices and technology integration services that make a difference in health care
  • Maintaining the effectiveness of the quality management system
  • Full compliance with applicable national and international standards

Global Instrumentation, LLC is an ISO 13485 certified, and US FDA registered, company.

Leadership Team

Jim DeMaso - President

Prior to leading the Company, Jim DeMaso began his career in the biomedical industry with Instruments for Cardiac Research, and subsequently held engineering leadership positions with Diagnostic Medical Instruments (DMI) and Spacelabs. Jim was at the forefront of the pioneering effort to evolve Holter technology from analog tape-based devices to a digital platform. Jim is a trustee of the International Society for Computerized Electrocardiology (ISCE) and a contributing member of the Cardiac Safety Research Consortium.

 

Craig Sellers – Vice President, Regulatory Affairs

Craig Sellers co-founded Global Instrumentation in 2002 and has since served in pivotal roles including leadership of embedded firmware design, new product development, and regulatory process development. He has 40+ years in electronic product design experience resulting in multiple patents and the successful development and marketing of numerous wireless, digital signal processing, and medical device products. Craig has 30+ years of medical regulatory management experience and has obtained medical device licenses to enable marketing of medical products in over 45 countries. Mr. Sellers holds BSEE, MSES, and MBA degrees.

 

Scott Myers - Vice President, Operations & Program Management

Scott Myers is a co-founder of Global Instrumentation and performs new product R&D and manages operations. Scott has 34+ years medical device product design and 16+ years managing operations. Scott has an ASEE & BSEE degree.

 

Doug Linquest – Vice President, Sales & Marketing

Doug has extensive experience in marketing, commercialization, and business development in the medical device industry. Prior to joining Global Instrumentation, Doug was chief marketing officer of HMicro, a Silicon Valley based firm offering semiconductor solutions for wireless wearable healthcare sensors. The majority of Doug’s career was spent at Welch Allyn in the global medical technology business where he held a variety of business leadership positions. He holds a B.A. degree from Colgate University and an M.B.A. from Syracuse University.

 

Customers & Collaborators

Global Instrumentation is proud to be working with the following organizations

News

December 17th, 2018 – Global Instrumentation, LLC releases M12A Software version 1.7.19.0 featuring enhanced review and editing tools.

November 15th, 2018 – Global Instrumentation, LLC achieves ISO 13485:2016 certification.

June 13th, 2018 – Global Instrumentation, LLC and the University of Rochester to collaborate on an NIH funded research project for a novel solution for home-based detection of Atrial Fibrillation.